These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33038086)

  • 1. Severe hypertension in China: results from the China PEACE million persons project.
    Li J
    J Hypertens; 2021 Mar; 39(3):461-470. PubMed ID: 33038086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project).
    Lu J; Lu Y; Wang X; Li X; Linderman GC; Wu C; Cheng X; Mu L; Zhang H; Liu J; Su M; Zhao H; Spatz ES; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    Lancet; 2017 Dec; 390(10112):2549-2558. PubMed ID: 29102084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, Awareness, and Treatment of Isolated Diastolic Hypertension: Insights From the China PEACE Million Persons Project.
    Mahajan S; Zhang D; He S; Lu Y; Gupta A; Spatz ES; Lu J; Huang C; Herrin J; Liu S; Yang J; Wu C; Cui J; Zhang Q; Li X; Nasir K; Zheng X; Krumholz HM; Li J; ;
    J Am Heart Assoc; 2019 Oct; 8(19):e012954. PubMed ID: 31566101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Prevalence, Awareness, and Characteristics of Isolated Systolic Hypertension Among Younger and Middle-Aged Adults in China.
    Mahajan S; Feng F; Hu S; Lu Y; Gupta A; Murugiah K; Gao Y; Lu J; Liu J; Zheng X; Spatz ES; Zhang H; Krumholz HM; Li J
    JAMA Netw Open; 2020 Dec; 3(12):e209743. PubMed ID: 33289843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional study.
    ; Zhou T; Wang Y; Zhang H; Wu C; Tian N; Cui J; Bai X; Yang Y; Zhang X; Lu Y; Spatz ES; Ross JS; Krumholz HM; Lu J; Li X; Hu S
    Lancet Glob Health; 2023 Jan; 11(1):e83-e94. PubMed ID: 36521957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Awareness, treatment and control of hypertension in 640 000 adults in eastern China].
    Yan XF; Yang JW; Bai XK; Wang HR; Feng F; Hou LL; Sun Y; Wang WJ; Li X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jan; 41(1):68-73. PubMed ID: 32062945
    [No Abstract]   [Full Text] [Related]  

  • 7. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015.
    Wang Z; Chen Z; Zhang L; Wang X; Hao G; Zhang Z; Shao L; Tian Y; Dong Y; Zheng C; Wang J; Zhu M; Weintraub WS; Gao R;
    Circulation; 2018 May; 137(22):2344-2356. PubMed ID: 29449338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of age and blood pressure among 3.3 million adults: insights from China PEACE million persons project.
    J Hypertens; 2021 Jun; 39(6):1143-1154. PubMed ID: 33967218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of hypertension prevalence, treatment and control rate among young and middle-aged population in China].
    Wang X; Zhou HH; Chen Z; Zhang LF; Zheng CY; Tian Y; Shao L; Zhu ML; Wang ZW; Gao R
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Dec; 50(12):1169-1176. PubMed ID: 36517437
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study.
    Meng XJ; Dong GH; Wang D; Liu MM; Lin Q; Tian S; Xu LX; Hou H; Ren YF; Lee YL
    J Hypertens; 2011 Jul; 29(7):1303-10. PubMed ID: 21558952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey.
    Wei J; Mi Y; Li Y; Xin B; Wang Y
    BMC Public Health; 2021 Mar; 21(1):423. PubMed ID: 33648483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension prevalence, awareness, treatment, and control in northeast China: a population-based cross-sectional survey.
    Zhang FL; Guo ZN; Xing YQ; Wu YH; Liu HY; Yang Y
    J Hum Hypertens; 2017 Dec; 32(1):54-65. PubMed ID: 29180804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, awareness, medication, control, and risk factors associated with hypertension in Yi ethnic group aged 50 years and over in rural China: the Yunnan minority eye study.
    Chen L; Zong Y; Wei T; Sheng X; Shen W; Li J; Niu Z; Zhou H; Zhang Y; Yuan Y; Chen Q; Zhong H
    BMC Public Health; 2015 Apr; 15():383. PubMed ID: 25886600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence, awareness, treatment and control of hypertension in a population over the age of 65 years: results from the Starnberg Study on Epidemiology of Parkinsonism and Hypertension in the Elderly (STEPHY).
    Trenkwalder P; Ruland D; Stender M; Gebhard J; Trenkwalder C; Lydtin H; Hense HW
    J Hypertens; 1994 Jun; 12(6):709-16. PubMed ID: 7963497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey.
    Su M; Zhang Q; Bai X; Wu C; Li Y; Mossialos E; Mensah GA; Masoudi FA; Lu J; Li X; Salas-Vega S; Zhang A; Lu Y; Nasir K; Krumholz HM; Jiang L
    Lancet; 2017 Dec; 390(10112):2559-2568. PubMed ID: 29102087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence, awareness, treatment and control of hypertension in Chinese adults].
    Gu DF; Jiang H; Wu XG; Reynolds K; Gan WQ; Liu DH; Su SY; Duan XF; Huang GY; Whelton PK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):84-9. PubMed ID: 12839656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012.
    Sengul S; Akpolat T; Erdem Y; Derici U; Arici M; Sindel S; Karatan O; Turgan C; Hasanoglu E; Caglar S; Erturk S;
    J Hypertens; 2016 Jun; 34(6):1208-17. PubMed ID: 26991534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of Dyslipidemia and Availability of Lipid-Lowering Medications Among Primary Health Care Settings in China.
    Lu Y; Zhang H; Lu J; Ding Q; Li X; Wang X; Sun D; Tan L; Mu L; Liu J; Feng F; Yang H; Zhao H; Schulz WL; Krumholz HM; Pan X; Li J;
    JAMA Netw Open; 2021 Sep; 4(9):e2127573. PubMed ID: 34586366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Body Mass Index With Blood Pressure Among 1.7 Million Chinese Adults.
    Linderman GC; Lu J; Lu Y; Sun X; Xu W; Nasir K; Schulz W; Jiang L; Krumholz HM
    JAMA Netw Open; 2018 Aug; 1(4):e181271. PubMed ID: 30646115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.